ArticleJournal of Yeungnam medical science2026
Evolution of fragile X syndrome and neurodevelopmental disorders research: a Scopus-based bibliometric analysis.
Article in Journal of Yeungnam medical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Neurodevelopmental disorders (NDD), including intellectual disability, autism spectrum disorder, attention-deficit hyperactivity disorder, and specific learning disorder, are closely linked to fragile X syndrome (FXS). This study employed a bibliometric analysis to explore trends and shifts in research focusing on FXS and NDD. We extracted publication data related to FXS and NDD from the Scopus database and conducted a bibliometric analysis. This involved assessing cumulative publication trends over time, most prolific authors, geographic distribution, and co-occurrence of author keywords to identify the dominant research themes. The number of publications on FXS and NDD has steadily increased over the past decades. The United States emerged as the leading contributor, while China is becoming an important player in the field. An analysis of author keywords revealed a significant shift in research focus from molecular mechanisms to translational and clinical research. This analysis provides critical insights into the evolving research landscapes of FXS and NDD. These findings can inform future research directions, facilitate collaboration, and optimize resource allocation. Additionally, they underscore the necessity for ongoing research to deepen our understanding of these disorders and enhance treatment options for affected individuals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.